End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-20 pm EDT
|
5-day change
|
1st Jan Change
|
7.36
CNY
|
-1.60%
|
|
+2.51%
|
-25.43%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
6,763
|
4,541
|
4,136
|
2,841
|
4,587
|
Enterprise Value (EV)
1 |
6,452
|
4,201
|
3,713
|
2,617
|
4,466
|
P/E ratio
|
64.8
x
|
217
x
|
76.2
x
|
442
x
|
276
x
|
Yield
|
0.31%
|
0.18%
|
0.3%
|
0.29%
|
0.2%
|
Capitalization / Revenue
|
6.02
x
|
6.03
x
|
4.16
x
|
3.15
x
|
4.84
x
|
EV / Revenue
|
5.74
x
|
5.58
x
|
3.74
x
|
2.91
x
|
4.71
x
|
EV / EBITDA
|
46.5
x
|
105
x
|
42.5
x
|
98.5
x
|
82.7
x
|
EV / FCF
|
125
x
|
150
x
|
516
x
|
170
x
|
-12.7
x
|
FCF Yield
|
0.8%
|
0.67%
|
0.19%
|
0.59%
|
-7.89%
|
Price to Book
|
5.58
x
|
3.74
x
|
3.01
x
|
2.07
x
|
2.66
x
|
Nbr of stocks (in thousands)
|
417,749
|
417,749
|
417,749
|
417,750
|
464,764
|
Reference price
2 |
16.19
|
10.87
|
9.900
|
6.800
|
9.870
|
Announcement Date
|
4/19/20
|
3/21/21
|
4/11/22
|
4/24/23
|
4/23/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,202
|
1,124
|
753.6
|
993.5
|
900.4
|
947.9
|
EBITDA
1 |
144.3
|
138.7
|
40.11
|
87.45
|
26.57
|
53.99
|
EBIT
1 |
121.2
|
111.6
|
13.32
|
61.26
|
-1.006
|
29.3
|
Operating Margin
|
10.08%
|
9.93%
|
1.77%
|
6.17%
|
-0.11%
|
3.09%
|
Earnings before Tax (EBT)
1 |
125.4
|
111.9
|
27.44
|
62.05
|
9.896
|
23.05
|
Net income
1 |
104.3
|
96.34
|
22.89
|
52.44
|
7.578
|
15.85
|
Net margin
|
8.68%
|
8.57%
|
3.04%
|
5.28%
|
0.84%
|
1.67%
|
EPS
2 |
0.2775
|
0.2500
|
0.0500
|
0.1300
|
0.0154
|
0.0358
|
Free Cash Flow
1 |
37.63
|
51.43
|
28.09
|
7.191
|
15.43
|
-352.5
|
FCF margin
|
3.13%
|
4.58%
|
3.73%
|
0.72%
|
1.71%
|
-37.18%
|
FCF Conversion (EBITDA)
|
26.08%
|
37.07%
|
70.03%
|
8.22%
|
58.08%
|
-
|
FCF Conversion (Net income)
|
36.07%
|
53.39%
|
122.69%
|
13.71%
|
203.62%
|
-
|
Dividend per Share
|
-
|
0.0500
|
0.0200
|
0.0300
|
0.0200
|
0.0200
|
Announcement Date
|
3/29/19
|
4/19/20
|
3/21/21
|
4/11/22
|
4/24/23
|
4/23/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
80
|
311
|
340
|
423
|
224
|
121
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
37.6
|
51.4
|
28.1
|
7.19
|
15.4
|
-352
|
ROE (net income / shareholders' equity)
|
11.8%
|
8.9%
|
1.78%
|
4.04%
|
0.55%
|
1.02%
|
ROA (Net income/ Total Assets)
|
6.29%
|
5.04%
|
0.55%
|
2.09%
|
-0.03%
|
0.79%
|
Assets
1 |
1,659
|
1,912
|
4,179
|
2,511
|
-26,313
|
2,009
|
Book Value Per Share
2 |
2.470
|
2.900
|
2.900
|
3.290
|
3.280
|
3.710
|
Cash Flow per Share
2 |
0.2100
|
0.3900
|
0.5000
|
0.7900
|
0.4400
|
0.3600
|
Capex
1 |
22.9
|
21
|
36.3
|
101
|
102
|
339
|
Capex / Sales
|
1.91%
|
1.87%
|
4.81%
|
10.13%
|
11.29%
|
35.71%
|
Announcement Date
|
3/29/19
|
4/19/20
|
3/21/21
|
4/11/22
|
4/24/23
|
4/23/24
|
|
1st Jan change
|
Capi.
|
---|
| -25.43% | 485M | | +18.48% | 67.02B | | +3.18% | 49.69B | | +20.44% | 42.41B | | +23.39% | 26.65B | | +12.41% | 19.62B | | +0.04% | 17.1B | | +4.18% | 15.64B | | -26.74% | 15.43B | | -12.35% | 15.3B |
Other Specialty Chemicals
|